You are here

Focus on increased low adherence in any oral cancer treatment

Interview with Andrea Antonuzzo, MD, recorded at ESMO, September 2014.

Interview with Andrea Antonuzzo, MD, recorded at ESMO, September 2014.

Adherence is a big problem in oral cancer therapy because low adherence leads to low efficacy, bad outcomes and bad quality of life. Dr. Andrea Antonuzzo sketches the reasons for bad adherence and what can be done to improve it. Further topics: the differences between patient care in clinical studies and the real-world clinical practice and why there is a need for trials with unselected patients and for more prospective studies with Quality of Life evaluation for new drugs, due to an increasing number of fast drug approvals where the toxicities are not very well known.

 

Andrea Antonuzzo, MD, is Head of Supportive Care Unit, Medical Oncology 1, at Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Search this site

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

NEW! Free access to the digital version of a new publication in Cancer Supportive Care


Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo

Share